Stephan Riedmaier

Statistics

Publications

Citations

666

H-Index

Active since

2008

Affiliations

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(Current)

AbbVie (United States)

University of Tübingen

Buck Institute for Research on Aging

Stephan Riedmaier is an author at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology specializing in pharmacology, biochemistry, and life sciences.

Publications per year

2008–2023

Publications

eIF2B activator prevents neurological defects caused by a chronic integrated stress response

Yao Liang Wong, Lauren LeBon, Ana M. Basso et al. · eLife · 2019 · 222 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

UDP-Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo

Stephan Riedmaier, Kathrin Klein, Ute Hofmann et al. · Clinical Pharmacology & Therapeutics · 2009 · 112 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Profiling Induction of Cytochrome P450 Enzyme Activity by Statins Using a New Liquid Chromatography-Tandem Mass Spectrometry Cocktail Assay in Human Hepatocytes

Diana M. Feidt, Kathrin Klein, Ute Hofmann et al. · Drug Metabolism and Disposition · 2010 · 95 citations

Medicine, Pharmacology, Toxicology +17

Distinction between Human Cytochrome P450 (CYP) Isoforms and Identification of New Phosphorylation Sites by Mass Spectrometry

Gorden Redlich, Ulrich M. Zanger, Stephan Riedmaier et al. · Journal of Proteome Research · 2008 · 67 citations

Life Sciences, Biochemistry, Pharmacology +16

Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis

Stephan Riedmaier, Kathrin Klein, Stefan Winter et al. · Frontiers in Pharmacology · 2011 · 53 citations · Full text

Medicine, Biochemistry, Pharmacology +13

1–5 of 10